(MedPage Today) — Oncologists risk misinterpreting the activity of immune checkpoint inhibitors (ICIs) and depriving patients of optimal outcomes if they do not account for the potential confounding effects of drugs that alter the immune system…
Source link : https://www.medpagetoday.com/hematologyoncology/othercancers/119630
Author :
Publish date : 2026-01-28 19:28:00
Copyright for syndicated content belongs to the linked Source.
